|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.75 HKD | 0.00% |
|
+0.17% | +61.52% |
| Jul. 15 | Beauty Farm Medical Conducts Share Buyback; Shares Slip 3% | MT |
| Jul. 14 | Correction: Beauty Farm Expects At Least 35% Rise in H1 Net Profit on Revenue Growth | MT |
Summary: Beauty Farm Medical and Health Industry Inc.
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Highlights: Beauty Farm Medical and Health Industry Inc.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses: Beauty Farm Medical and Health Industry Inc.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings Chart: Beauty Farm Medical and Health Industry Inc.
Source: Surperformance
| Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
|---|---|---|---|---|---|
| 886M | |||||
| 226M | |||||
| 145M | |||||
| - | 108M | ||||
| - | 92.52M | ||||
| Average | 291.46M | ||||
| Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
-
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 2373 Stock
- Ratings Beauty Farm Medical and Health Industry Inc.
Select your edition
All financial news and data tailored to specific country editions
